MedPath

PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability

Completed
Conditions
Pulmonary Embolism
Dyspnea
Thoracic Pain
Registration Number
NCT02360540
Lead Sponsor
University Hospital, Angers
Brief Summary

PERC rule was created to rule out pulmonary embolism (PE) without further exams, with residual PE risk \<2%. Its safety is currently confirmed in low PE prevalence populations as north-American. In European high PE prevalence population, it has been showed that PERC rule used alone or associated with low clinical probability assessed by revised Geneva score (RGS) was not safe. In retrospective study, we suggest that the combination of PERC rule with implicit clinical probability (gestalt) could allow the use of the PERC rule.

PERCEPIC, an observational prospective multicenter study performed in France and Belgium, will test this hypothesis. Therefore, 3000 patients will be included in 12 centers. Primary outcome will be the rate of thromboembolic events or death related or possibly related to PE in patients with low implicit clinical probability and negative PERC rule (8 criteria absents). Upper limit of confidence interval of this rate must be equal or lower than 3% to consider PERC rule as safe in this combination.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1773
Inclusion Criteria
  • Patients admitted to the emergency department for one of the following criteria :
  • Dyspnea and/or Thoracic pain without another obvious cause
  • Pulmonary embolism suspicion whatever the reason
Exclusion Criteria
  • Age lower than 18
  • Patients hospitalized for more than 48h
  • Ongoing curative anticoagulant therapy for more than 48h before admission
  • Patients with thromboembolic disease diagnosed before the admission
  • Unavailability for follow-up (short life expectancy, no phone number...)
  • Patient refusing to be contacted by phone at 3 month
  • Patient refusing that medical data were collected
  • Secondary exclusion criteria : curative anticoagulant therapy for more than 5 days during the 3 month follow-up for another reason than thromboembolic disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the accuracy of the combination of low implicit clinical probability (gestalt) and negative PERC rule (8 criteria absents)3 months

Rate of thromboembolic events or death related or possibly related to PE in patients with low implicit clinical probability and negative PERC rule. Upper limit of confidence interval of this rate must be equal or lower than 3% to consider PERC rule as safe in this combination

Secondary Outcome Measures
NameTimeMethod
To assess usefulness of PERC and implicit low clinical probability combination to reduce the use of further examsDuring emergency managment

Mean number of further exams performed per diagnostic strategy

To assess the accuracy of PERC and low clinical probability combination depending of clinical probability assessment method (implicit assessment, revised Geneva Score, Wells Score and implicit overridden Geneva Score)3 months

For each methods, AUC in receiver operating characteristic analyses of the 3-level classification scheme will be compared.

To compare performances of clinical probability assessment methods : implicit assessment, revised Geneva Score, Wells Score and implicit overridden Geneva Score3 months

For each methods, AUC in receiver operating characteristic analyses of the 3-level classification scheme will be compared

Trial Locations

Locations (12)

Clinique Universitaire Saint-Luc

🇧🇪

Bruxelles, Belgium

UH Liège

🇧🇪

Liège, Belgium

Hospital of Agen

🇫🇷

Agen, France

UH Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

UH Angers

🇫🇷

Angers, France

Hospital of Argenteuil

🇫🇷

Argenteuil, France

UH Nantes

🇫🇷

Nantes, France

UH Poitiers

🇫🇷

Poitiers, France

UH Rennes

🇫🇷

Rennes, France

Hospital of Le Mans

🇫🇷

Le Mans, France

Hospital of Saint-Brieuc

🇫🇷

Saint-Brieuc, France

UH Erasme

🇧🇪

Bruxelles, Belgium

© Copyright 2025. All Rights Reserved by MedPath